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Summary 
The endoplasmic reticulum (ER)-resident stress protein gp96 induces protective immunity and 
specific cytotoxic T lymphocyte (CTL) responses against  antigens expressed in those cells it has 
been isolated from. This ability is based on peptides associated with gp96. Because gp96 is lo- 
cated inside the ElL, our experiments address the question whether or not the repertoire of 
peptides associated with gp96 is influenced by the transporter associated with antigen process- 
ing (TAP).  For this purpose, gp96 was isolated from cells with and without a TAP defect and 
used for immunization of mice. We found that for some antigens the association of peptides 
with gp96 required functional TAP molecules, whereas the association of peptides from other 
antigens was TAP independent. In the case of a TAP-dependent association of peptides with 
gp96, our results prove that peptide binding by gp96 in vivo occurs inside the EP,. and is not an 
artifact induced by cell lysis during the gp96 purification. The finding that some antigens can 
also associate  with gp96 in the absence of functional TAP molecules indicates that the reper- 
toire ofpeptides bound by gp96 truly reflects the entire repertoire ofpeptides present inside the 
Et( and not only those peptides transported by TAP. These results,  together with the earlier 
finding that the gp96 peptide repertoire is independent of the major histocompatibility com- 
plex molecules expressed by the cell gp96 is isolated from, give the theoretical foundation for 
the ability ofgp96 to induce CTL responses against  all kinds ofintracellular antigens. 
I 
mmunizations  with  the  stress  protein  gp96  have  been 
shown to induce specific CTL responses against  a variety 
of intracellular antigens, including viral and minor H  anti- 
gens and also protective immunity against tumors from which 
gp96 was isolated (1-4). This ability of gp96 has been at- 
tributed to peptides derived from intracellular proteini that 
associate  with gp96 inside the endoplasmic reticulum (Ell.) 
(5).  In  support  of this  is  the  finding that  dissociation  of 
bound peptides leads to abrogation of the gp96 immunoge- 
nicity (5). 
The mechanism by which peptides associate with gp96 is 
not known but it has been postulated that peptides translo- 
cated by the transporter associated with antigen processing 
(TAP)  are  accepted by gp96  and  that  gp96  assists in  the 
loading of peptides  onto MHC  class I  molecules (6).  In- 
deed, we were able to show recently that in streptolysin- 
O-permeabilized  cells,  peptides  translocated into  the  EI~ 
are able to bind to gp96 in a TAP-dependent fashion (7). 
This leaves  open  the  possibility that  gp96  is  directly in- 
volved in the loading of peptides onto MHC molecules, as 
might apply perhaps to those MHC molecules that do not 
associate with TAP, a process that can be mediated by tapa- 
sin in human cells  (8, 9).  On the other hand, gp96 might 
play a role in the handling of peptides unable  to bind to 
MHC molecules without further modifications. The fate of 
such peptides, thought to represent the majority of TAP- 
transported peptides, is unknown but they might be sub- 
jected to ~nming or degradation or to export from the ElL, 
possibly by the Sec61  transporter. This complex has been 
shown  to translocate glycoproteins from the Et( back to 
the  cytosol (10,  11).  Interestingly, we found that gp96 is 
able to bind glycosylated peptides, which could be an indi- 
cation that it supplies Sec61 with proteins destined for ER 
export (7).  Using gp96 to induce cross-priming, we have 
shown earlier that the repertoire ofpeptides associated with 
gp96 is not influenced by the MHC molecules present in 
the cell but seem to reflect the complete immunological in- 
formation of a cell (4). This would make gp96 an ideal can- 
didate for the induction of immune responses, especially in 
those cases where the antigens or T  cell epitopes have not 
been identified. But so far, the binding ofpeptides to gp96 
inside the ER in intact cells has not been shown directly 
and the possibility that this association is induced as a result 
of cell  lysis  during  the  gp96  purification  cannot  be  ex- 
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unpredictable,  weakening  the  potential  use  of gp96  for 
therapeutical applications. Therefore, we decided to inves- 
tigate  the  influence  of TAP  on  gp96  peptide  association 
and  thereby identify the  compartment  where  gp96  binds 
peptides. We isolated gp96 from RMA  and TAP2-defec- 
tive  RMA-S  cells  expressing  13-galactosidase  (/3-gal)  and 
several minor H  antigens and tested the ability of these dif- 
ferent gp96 preparations to induce specific CTL responses. 
Materials  and Methods 
Mice and Antibodies.  BALB/c,  B10.D2,  BALB.B,  129/Sv, 
and C57BL/6  mice were  obtained from Charles River WIGA 
(Sulzfeld,  Germany) and were maintained in the animal facilities 
at the Institute for Cell Biology. Antibodies to gp96 (anti-grp94, 
SPA-850, clone 9G10) were obtained from Stressgen Biotechnol- 
ogies Corp. (Victoria, BC, Canada). 
Purification afgp96,  gp96  was  purified  as  described  (4).  In 
brief, P815, P13.1, RMA, RMA-S cells, or their [3-gal transfec- 
tants were grown in roller bottles to generate a 60-ml cell pellet. 
This pellet was homogenized in 200 ml ofhypotonic buffer (30 mM 
NaHCO3, 0.5 mM PMSF, pH 7.1) and separated from the super- 
natant by a 100,000 g centrifugation. The supernatant was applied 
to a Con A-Sepharose column and eluted with PBS containing 
1 mM MgC12,  2  mM KC1,  and 6% o¢-methyl-mannoside. The 
eluate was dialyzed against 5 mM phosphate buffer, pH 7.0, and 
separated on  FPLC  using a  MonoQ  column  (5/5,  Pharmacia) 
with a NaC1 gradient from 0  to  1 M.  Fractions were  tested in 
SDS-PAGE and Western blot analysis  using a mAb specific for 
gp96.  Only fractions containing gp96  and  no  other  detectable 
contaminating proteins were pooled and concentrated using cen- 
tricon  10  microconcentrators (Amicon). The  approximate con- 
centration was determined by measuring the OD at 280 nm using 
an extinction coettqcient of 1.0. 
Immunization of Mice and Generation of CTL.  8- to 10-wk-old 
female BALB/c and  129/Sv mice were immunized intraperito- 
neally with 107 irradiated C57BL/6 spleen cells (33 Gy) in 300 I*1 
PBS or with 30 ~g gp96 purified from different cell lines in 300 p,1 
PBS.  10 d later, spleens were removed and the splenocytes were 
stimulated with irradiated (33  Gy) spleen cells from B10.D2  or 
C57BL/6 mice or synthetic [3-gal peptide (TPHPARIGL; 1 b~M) 
for5 d. 
CelI CultureandCTLAssays.  RMA,  RMA-S,  P815,  and 
P13.1  (12)  cells  were  cultured in RPMI-1640  containing  10% 
FCS, 2-ME, Dglutamine, and antibiotics. CTL lines were gener- 
ated by weekly restimulations with  irradiated spleen cells from 
B10.D2 or C57BL/6 mice and synthetic peptides, if applicable, as 
described (13).  CTL assays were performed as described (13) us- 
ing RMA, RMA-S, P815, P13.1, and Con A blasts of spleen cells 
as target cells. Con A blasts were generated as described (14). 
fl-Gal  Transfection and  Determination  of  ~8-Gal  Expression. 
RMA and RMA-S cells were cotransfected with 2 leg of the plas- 
mid pCH110  (Pharmacia) expressing the Escherichia coli-derived 
[3-gal under the control of the SV40 promotor and 10 leg of the 
plasmid pBJlneo  to  allow G418  selection of the  transfectants. 
Transfectants were selected with 1 mg/ml G418  (GIBCO BRL, 
Gaithersburg, MD).  Surviving cells were  cloned and tested for 
their  expression  of [3-gal  by  their  ability to  cleave  X-gal  (5- 
bromo-4-chloro-3-indolyl-[3-D-galactoside). Cleavage  of  X-gal 
was determined by incubating serial dilutions of an  1% NP-40 
cell lysate of 106 transfectants with 2.5 Ixg X-gal in 100 p,1 PBS at 
37°C and measuring the absorbance at 620 nm after 8 h. Clones 
with comparable [3-gal activity were selected and expanded for 
the purification of gp96. 
Results 
Generation  of ~-GaI-specific  CTL  with gp96 from  ~8-Gal 
Transfectants Expressing  Functional or Nonfunctional TAP Mol- 
ecules.  To test the hypothesis that peptide binding to gp96 
occurs  inside  the  ER  we  transfected  RMA  and  RMA-S 
cells with  E.  coli-derived [3-gal resulting in  cytosolic ex- 
pression  of the  protein  (12).  [3-gal-transfected RMA  and 
RMA-S  cell clones, called R/gal and RS/gal and express- 
ing similar levels of the protein were selected (Fig.  1)  and 
expanded for the purification ofgp96 according to standard 
protocols  (4).  BALB/c  mice  were  immunized  with  these 
gp96 preparations and as a control with gp96 from P815  or 
P13.1, the 13-gal transfectant ofP815. As shown in Fig. 2 A, 
only the immunization with gp96 from P13.1 but not P815 
induces a CTL response against P13.1  or peptide-incubated 
P815  cells, underlining the specificity of the gp96 immuni- 
zation. As shown in Fig. 2  B, the induction of [3-gal--spe- 
cific CTL  requires the presence of functional TAP  mole- 
cules,  because  only the  gp96  preparation from  R/gal but 
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Figure  1.  Determination  of [3-gal expression in R/gal and  RS/gal 
transfectants. Serial dilutions ofNP-40 lysates of R/gal (open triangles) and 
RS/gal (closed triangles) transfectants  or untransfected RMA cells (closed  cir- 
des) were incubated with the chromogenic substrate X-gal and enzyme 
activity was determined by measuring the absorbance at 620 nm. 
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Figure 2.  Induction of 13-gal-specific  CTL responses  using gp96 mole- 
cules isolated from P815, P13.1, R/gal, and RS/gal cells. (A) BALB/c 
mice were immunized with gp96 molecules isolated from P815 cells (open 
triangles), P13.1 cells (closed triangles), or with PBS (closed circles). Spleen 
cells were  stimulated in  vitro  with  the  13-gal-derived peptide  TPH- 
PARIGL and the CTL activity was tested on P13.1 cells at the indicated 
E/T ratio or on P815 incubated with different concentrations of the 13-gal 
peptide at an E/T ratio of 3:1. (B) BALB/c mice were immunized with 
gp96 molecules isolated from  RS/gal cells (open triangles), P,./gal cells 
(closed triangles), or PBS  (closed circles). Spleen cells were stimulated and 
CTL activity was determined as described in A. 
not RS/gal cells is able to induce  CTL recognizing P13.1 
or  13-gal  peptide-incubated  P815  cells.  This  experiment 
clearly shows that  [3-gal-derived peptides are loaded onto 
gp96  molecules inside  the  ER,  as  this  process is  not  ob- 
served in cells with a TAP defect. These results were repro- 
duced in three independent experiments with a gp96 con- 
centration (30 p~g), which is in threefold excess of the amount 
required for optimal tumor protection (2) and CTL induc- 
tion, as determined by titrations of gp96 over a range from 
2 to 30 v~g (data not shown). 
Figure 3.  Induction  of minor H-specific CTL using gp96 molecules 
isolated from R/gal and RS/gal cells in BALB/c mice. Mice were immu- 
nized with PBS (closed circles) or gp96 molecules isolated from P,S/gal 
(open triangles), P,/gal (closed triangles) to induce cross-priming against mi- 
nor H antigens of the C57BL/6 background. Spleen cells were stimulated 
in vitro with B10.D2 stimulator cells and tested for their ability to lyse 
BALB/c (left)  and B10.D2 (right) Con A blasts. 
Generation  of Minor  H-specific  CTL  with gp96 from  Cells 
Expressing Functional or Nonfunctional  TAP Molecules.  In  the 
following  experiments,  we  analyzed  whether  the  TAP- 
dependent peptide loading of gp96  molecules is a  general 
phenomenon  that  can  be  observed for  other  antigens  as 
well.  Therefore,  BALB/c  mice  (H-2  a)  were  immunized 
with  gp96  molecules from R/gal  and RS/gal  cells to  in- 
duce  cross-priming against minor H  antigens expressed in 
C57BL/6 mice (H-2b), from which P,./gal and RS/gal cells 
were generated. The spleen cells from the immunized mice 
were  stimulated with B10.D2  splenocytes (H-2d),  sharing 
most of the minor H  antigens with C57BL/6. As shown in 
Fig.  3,  spleen  cells from  the  untreated  mice  showed  no 
CTL  activity, because  the  induction  of minor H-specific 
CTL  requires in vivo priming  (15),  but  spleen cells from 
mice immunized with gp96 preparations from both l~./gal 
and RS/gal displayed CTL activity against B10.D2  Con A 
blasts.  A  contamination  of gp96  molecules  from  RS/gal 
cells with those from R/gal cells can be excluded because 
in  some  experiments  spleen  cells  from  mice  immunized 
with kS/gal gp96 were also stimulated with [3-gal peptides 
and never showed [~-gal-specific CTL activity. The results 
could  also be  reproduced with  gp96  molecules from un- 
transfected RMA and RMA-S cells (data not shown). There- 
fore, these experiments show that the loading of peptides, 
reflecting some of the minor H  antigens that differ between 
BALB and C57BL mice, onto gp96 molecules is indepen- 
dent of TAP. The origin of these minor H  antigens is not 
known, but obviously their peptides enter the ER  and are 
loaded onto gp96 molecules by a TAP-independent mech- 
anism. This is not a rare phenomenon because some minor 
H  antigens can be also recognized by H-2b-restricted CTL 
in  a  TAP-independent fashion,  as  shown  earlier (14)  and 
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Figure  4.  TAP-independent recognition of minor  H  antigens  by 
BALB.B  anti-C57BL/6  CTL.  BALB.B mice  were  immunized with 
C57BL/6 spleen cells (closed symbols)  or left untreated (open symbols)  and 
stimulated in vitro with irradiated C57BL/6 cells. CTLs were tested for 
their ability to recognize RMA cells (triangles) or RMA-S cells (circles). 
again in Fig. 4. RMA and RMA-S cells are lysed compara- 
bly by  CTL  specific  for  minor  H  antigens  differing be- 
tween  BALB.B  and  C57BL/6  mice,  now  presented  by 
MHC molecules of the H-2  b haplotype. TAP-independent 
loading of peptides onto gp96 and MHC class I molecules 
is not observed in all minor H  incompatible strain combi- 
nations. When we immunized 129/Sv mice with gp96 mole- 
cules  from RMA  or RMA-S  cells  to  induce  a  CTL re- 
sponse against minor H-antigens that differ between 129/Sv 
and C57BL/6 mice, we observed that only gp96 molecules 
from tkMA but not RMA-S cells were able to generate a 
minor H-specific CTL response (Fig.  5 A). This is in con- 
trast with the experiments shown in Fig. 3 where the iden- 
tical tkMA-S gp96 preparation induced a CTL response in 
BALB/c  mice against B10.D2  Con A  blasts.  In line with 
the above results, only RMA but not R.MA-S cells are rec- 
ognized by the minor H-specific CTL induced by immuni- 
zation of 129/Sv mice with C57BL/6 cells or RMA-derived 
gp96  molecules  (Fig.  5  B).  This  supports  the  notion  that 
peptide loading onto MHC and gp96 molecules happens in 
the same intracellular compartment. 
Discussion 
Our results clearly show that the loading of gp96 mole- 
cules with T  cell-recognized antigens is TAP  dependent. 
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Figure  5.  Induction of minor H-specific CTL in 129/Sv  mice upon 
immunization with gp96  molecules isolated from RMA and RMA-S 
cells. Mice were irmnunized with gp96 molecules isolated from R.MA-S 
cells (open  triangles),  RMA  cells (closed triangles),  C57BL/6  spleen cells 
(open drcles) or with PBS (closed circles) to induce priming against minor H 
antigens of the C57BL/6 strain. Spleen cells were stimulated in vitro with 
C57BL/6 stimulator cells and tested for their ability to lyse 129/Sv and 
C57BL/6 Con A blasts (A) or RMA and tkMA-S target cells (B). 
Thus,  gp96 must associate with peptide ligands inside the 
ER  and its ability to induce specific CTL responses against 
antigens expressed in the cells from which it has been puri- 
fied is not an artifact due to cell lysis during gp96 purifica- 
tion.  This  is  evident from  the  immunization experiments 
with gp96 molecules isolated from cells with or without a 
defect in the TAP2 molecules and expressing a defined an- 
tigen,  [3-gal,  exclusively in the  cytosol.  Only gp96 mole- 
cules isolated from TAP-competent cells induced a specific 
CTL  response,  indicating the  association of [3-gal-derived 
peptides with gp96 (Fig. 2). The same was observed for the 
induction ofa CTL response against C57BL/6 cells in 129/Sv 
mice.  Gp96  from  RMA  but not from  RMA-S  cells was 
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5  A).  This  effect is not  due  to variations in the  quality  of 
the  gp96 preparations  from the  different  cell lines  because 
identical  gp96  preparations  from RS/gal  or RMA-S  cells 
that failed to induce TAP-dependent  [~-gal or 129/Sv anti- 
C57BL/6  minor H-specific CTL responses were able to in- 
duce  TAP-independent  BALB/c  anti  C57BL/6  minor 
H-specific  CTL  (Fig.  3).  In some cases, this was observed 
in  CTL  cultures  derived  from the  same mouse  (Fig.  2  B; 
Fig. 3). We also observed that CTL induced by immuniza- 
tion  with  C57BL/6  spleen  cells  or  RMA-derived  gp96 
molecules  recognized  RMA  but  not  RMA-S  target  cells 
(Fig.  5  B).  This shows that not only the  gp96 but also the 
MHC  molecules  of RMA-S  cells  completely  lack  those 
minor  H  antigen-derived  peptides  that  are  recognized  by 
129/Sv  anti C57BL/6  CTL.  These experiments,  revealing 
a  TAP-dependent  loading  of peptides  onto  gp96  mole- 
cules, are complemented by results obtained in vitro where 
radiolabeled peptides were added to streptolysin-O-perme- 
abilized cells. In this study, it was shown that peptides asso- 
ciated with  gp96 molecules  only when  the  cells expressed 
functional TAP molecules and ATP was present (7, 16). 
On the other hand, not all peptides associated with gp96 
molecules depend on the presence of functional  TAP mol- 
ecules.  This is evident from the  ability of both RMA  and 
RMA-S  gp96 preparations to induce  cross-priming against 
B10.D2  cells in BALB/c mice (Fig. 3). For at least a subset 
of these H-2d-restricted peptides, the association with gp96 
molecules is TAP independent.  Interestingly,  the presenta- 
tion ofH-2b-restricted peptides in a similar combination of 
minor H  antigens was also found to be TAP-independent: 
BALB.B-derived  CTL  specific  for  C57BL/6  cells  recog- 
nize  RMA  and  RMA-S  cells  to  a  similar  extent  (Fig.  4). 
RMA-S cells have been previously reported to present other 
peptide  antigens  including  minor H  antigens  despite  their 
mutation  in  the  TAP2  gene  (14,  17).  This  presentation 
seems to be due to luminal production  or to unknown  in- 
trinsic  properties  of these  peptides,  allowing  either  TAP- 
independent  or just TAPl-mediated  transport (16). 
The above experiments indicate  that gp96 does not  ex- 
clusively receive its peptides from TAP molecules but also 
binds peptides that are present inside the ER due to TAP- 
independent  translocation  or that are generated  inside  the 
ER  directly,  possibly from ER-resident  proteins.  Our  ex- 
periments  might  also  provide  an  answer  to  the  question 
how  MHC  molecules  are  loaded  with  peptides  in  TAP- 
deficient cell lines. In this situation, a direct loading of MHC 
molecules via their association with TAP  (8,  18),  or medi- 
ated by tapasin in human cells (19), is not possible. It seems 
feasible  that  gp96  or  other  ER-resident  peptide-binding 
proteins like a  60-kD protein identified by Lammert et al. 
(7)  or  Marusina  et  al.  (16),  could  be  involved  in  these 
events. This might also include MHC  class I loading of those 
peptides  that require  further  processing before their bind- 
ing  to  MHC  molecules  (20)  and  the  removal  of peptides 
from the ER that do not posses the constraints imposed by 
the ligand motif of the MHC  molecules present in the ER. 
These  functions  were  proposed  for BiP  (21)  based  on  its 
ability  to  bind  peptides  in  vitro  (22).  But  it  was  clearly 
shown recently that BiP is not able to bind peptides trans- 
located by TAP in streptolysin-O-permeabelized cells (7, 16). 
Therefore,  new  candidates,  like  gp96  or  the  60-kD  pro- 
tein, are required for these services. 
Even  though  the  physiological  role  of gp96  is  not  de- 
fined yet, our results show that its peptide repertoire seems 
to reflect all the peptides  that have entered the ER,  either 
by  TAP-dependent  or  -independent  mechanisms.  Com- 
bined  with  its  ability  to  induce  protective  immune  re- 
sponses in vivo against a wide variety of antigens, including 
tumor  antigens  that  are  not  further  identified,  our  results 
provide  the  theoretical  foundation  for  applying  gp96  for 
the  induction  of immune  responses  against  all  peptides 
present in the ER, including those that are able to associate 
with MHC  molecules. 
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